Please login to the form below

Not currently logged in
Email:
Password:

Burton Paul appointed to 1HQ’s health division

Burton Paul has been appointed as new client director to global branding agency 1HQ to head up its health division

Burton Paul has been appointed as new client director to global branding agency 1HQ to head up its health division

Paul brings more than 15 years experience in managing projects and clients across a wide range of sectors including FMCG and pharmaceuticals. His work includes brand delivery for some of the biggest names in the sector, most notably: Adcock Ingram, Arrow Generics, BMS, Cephalon, Eusa Pharma, GE Healthcare, King Pharmaceuticals, Mylan, Peptech, SSL (Reckitt Benckiser) and Synpart.  

Mark Artus, CEO of 1HQ, said: “Burton's appointment marks a signal of intent from 1HQ to significantly enhance our existing health and pharma offering. His experience in the pharmaceutical industry will provide 1HQ Health with unrivaled insight into the pharma industry, ensuring we can be a leading branding force within the sector.

He continued: “Burton wanted to join 1HQ because he saw an ever-widening gap between the research and development process and the marketers in the industry, and saw a great opportunity with us and the way we think.”

Paul said: “Semiotics in particular has a huge role to play in the development of pharma products especially in over the counter products. The pharma industry need to think more like retailers; especially as their brands sit on the shelf with all the best household brands, which is an area I am looking forward to developing.”

Paul continued: “Having worked on a global scale across many brands, I have developed a real passion and drive to make a difference. It was important for me to work with a team that shared that vision and I recognise shared core values at 1HQ. It's an exciting time to join the agency and I look forward to developing 1HQ Health into a powerhouse of the branding world.”

9th August 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected healthcare organisations to create powerful digital experiences. We help our...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics